BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33430005)

  • 1. Efficiency of Diagnostic Testing for
    Rojas García P; van der Pol S; van Asselt ADI; Postma M; Rodríguez-Ibeas R; Juárez-Castelló CA; González M; Antoñanzas F
    Antibiotics (Basel); 2021 Jan; 10(1):. PubMed ID: 33430005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Testing for Sepsis: A Systematic Review of Economic Evaluations.
    Rojas-Garcia P; van der Pol S; van Asselt ADI; Postma MJ; Rodríguez-Ibeas R; Juárez-Castelló CA; González M; Antoñanzas F
    Antibiotics (Basel); 2021 Dec; 11(1):. PubMed ID: 35052904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The health economics of Helicobacter pylori infection.
    Moayyedi P
    Best Pract Res Clin Gastroenterol; 2007; 21(2):347-61. PubMed ID: 17382282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.
    Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
    Value Health; 2013; 16(2):231-50. PubMed ID: 23538175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of empirical antisecretory therapy versus Helicobacter pylori test for management of dyspepsia: a randomized trial in primary care.
    Jarbol DE; Bech M; Kragstrup J; Havelund T; Schaffalitzky de Muckadell OB
    Int J Technol Assess Health Care; 2006; 22(3):362-71. PubMed ID: 16984065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The management of Helicobacter pylori infection in primary care: a systematic review of the literature.
    Childs S; Roberts A; Meineche-Schmidt V; de Wit N; Rubin G
    Fam Pract; 2000 Aug; 17 Suppl 2():S6-11. PubMed ID: 10960429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and economic consequences.
    Ofman JJ; Etchason J; Fullerton S; Kahn KL; Soll AH
    Ann Intern Med; 1997 Feb; 126(4):280-91. PubMed ID: 9036800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview.
    Veldhuyzen van Zanten SJ; Sherman PM
    CMAJ; 1994 Jan; 150(2):177-85. PubMed ID: 8287340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of current diagnostic methods and advances in
    Pohl D; Keller PM; Bordier V; Wagner K
    World J Gastroenterol; 2019 Aug; 25(32):4629-4660. PubMed ID: 31528091
    [No Abstract]   [Full Text] [Related]  

  • 11. Noninvasive Helicobacter pylori testing for the "test-and-treat" strategy: a decision analysis to assess the effect of past infection on test choice.
    Chey WD; Fendrick AM
    Arch Intern Med; 2001 Sep; 161(17):2129-32. PubMed ID: 11570943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility and cost effectiveness of Helicobacter pylori testing for patients with duodenal and gastric ulcers.
    Greenberg PD; Koch J; Cello JP
    Am J Gastroenterol; 1996 Feb; 91(2):228-32. PubMed ID: 8607485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs of diagnosis and treatment of Helicobacter pylori infection: when does choosing the treatment regimen based on susceptibility testing become cost effective?
    Breuer T; Graham DY
    Am J Gastroenterol; 1999 Mar; 94(3):725-9. PubMed ID: 10086658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indications for treatment of Helicobacter pylori infection: a systematic overview.
    Veldhuyzen van Zanten SJ; Sherman PM
    CMAJ; 1994 Jan; 150(2):189-98. PubMed ID: 8287341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-effectiveness of diagnostic testing strategies for Helicobacter pylori.
    Vakil N; Rhew D; Soll A; Ofman JJ
    Am J Gastroenterol; 2000 Jul; 95(7):1691-8. PubMed ID: 10925969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial management strategies for dyspepsia.
    Delaney B; Ford AC; Forman D; Moayyedi P; Qume M
    Cochrane Database Syst Rev; 2005 Oct; (4):CD001961. PubMed ID: 16235292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial: a randomized trial of early endoscopy, Helicobacter pylori testing and empirical therapy for the management of dyspepsia in primary care.
    Duggan AE; Elliott CA; Miller P; Hawkey CJ; Logan RF
    Aliment Pharmacol Ther; 2009 Jan; 29(1):55-68. PubMed ID: 18801056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial management strategies for dyspepsia.
    Delaney BC; Moayyedi P; Forman D
    Cochrane Database Syst Rev; 2003; (2):CD001961. PubMed ID: 12804417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of initial noninvasive therapy in pediatric patients presenting with suspected ulcer disease.
    Olson AD; Fendrick AM; Deutsch D; Chernew ME; Hirth RA; Patel C; Bloom BS
    Gastrointest Endosc; 1996 Nov; 44(5):554-61. PubMed ID: 8934161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Test and treat strategies for Helicobacter pylori in uninvestigated dyspepsia: a Canadian economic analysis.
    Marshall JK; Armstrong D; O'Brien BJ
    Can J Gastroenterol; 2000 May; 14(5):379-88. PubMed ID: 10851277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.